Reborna Biosciences, Inc.

Importer · Japan

Biotechnology / Drug Discovery

About Reborna Biosciences, Inc.

Reborna Biosciences, Inc. is a Japanese biotech startup founded in 2018, specializing in the development of RNA-targeting small molecule drugs for rare genetic diseases. Utilizing a proprietary screening method that replicates the natural three-dimensional structure of RNA, the company aims to discover orally available small molecules with high clinical relevance. Reborna's mission is to provide innovative therapeutic options for patients suffering from rare genetic conditions. Reborna Biosciences, Inc. is a Japanese biotech startup founded in 2018, specializing in the development of RNA-targeting small molecule drugs for rare genetic diseases. Utilizing a proprietary screening method that replicates the natural three-dimensional structure of RNA, the company aims to discover orally available small molecules with high clinical relevance. Reborna's mission is to provide innovative therapeutic options for patients suffering from rare genetic conditions. Company LinkedIn URL: Not Available